Literature DB >> 17133100

Toll-like receptors and innate immunity in gut homeostasis and pathology.

Kathrin S Michelsen1, Moshe Arditi.   

Abstract

PURPOSE OF REVIEW: Immune responses to commensal bacteria and resulting chronic inflammation are hallmarks of inflammatory bowel disease. Considerable evidence has accumulated to suggest that innate immune defense mechanisms interact with pro-inflammatory pathways and exacerbate or perhaps even initiate development of inflammatory bowel disease. RECENT
FINDINGS: Recent cellular and mouse studies now show Toll-like receptor responses in intestinal epithelial cells are polarized and their activation by commensal bacteria plays an essential role in maintaining colonic homeostasis and controlling tolerance in the gut. Recent data also implicate signaling by Toll-like receptors and the common adaptor molecule MyD88 in intestinal epithelial homeostasis as well as the pathogenesis of inflammatory bowel disease, establishing a key link between the innate and adaptive immune defenses.
SUMMARY: We review recent progresses in the understanding of the role of Toll-like receptors and other pattern recognition receptors in the host defense against gastrointestinal pathogens and maintenance of immune tolerance to commensal bacteria, highlighting areas that should provide fertile ground for future studies aimed at a more comprehensive understanding of the interplay between innate and adaptive immune defense mechanisms and inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133100     DOI: 10.1097/00062752-200701000-00010

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  21 in total

1.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.

Authors:  Mark J Asquith; Olivier Boulard; Fiona Powrie; Kevin J Maloy
Journal:  Gastroenterology       Date:  2010-04-28       Impact factor: 22.682

Review 2.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

Review 3.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

4.  Commensal microbiota drive proliferation of conventional and Foxp3(+) regulatory CD4(+) T cells in mesenteric lymph nodes and Peyer's patches.

Authors:  Sascha Cording; Diana Fleissner; Markus M Heimesaat; Stefan Bereswill; Christoph Loddenkemper; Satoshi Uematsu; Shizuo Akira; Alf Hamann; Jochen Huehn
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

5.  LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock.

Authors:  Ruiming Chang; Yingyan Wang; Jianxing Chang; Liqiang Wen; Zhipeng Jiang; Tao Yang; Kai Yu
Journal:  Inflamm Res       Date:  2014-05-20       Impact factor: 4.575

6.  Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children.

Authors:  S Murugesan; M Ulloa-Martínez; H Martínez-Rojano; F M Galván-Rodríguez; C Miranda-Brito; M C Romano; A Piña-Escobedo; M L Pizano-Zárate; C Hoyo-Vadillo; J García-Mena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-12       Impact factor: 3.267

Review 7.  Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.

Authors:  D R Kaufman; D H Barouch
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway.

Authors:  Nan Gao; Ashok Kumar; Jeevan Jyot; Fu-Shin Yu
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

9.  ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.

Authors:  Sung Hee Lee; Li-Li Hu; Jose Gonzalez-Navajas; Geom Seog Seo; Carol Shen; Jonathan Brick; Scott Herdman; Nissi Varki; Maripat Corr; Jongdae Lee; Eyal Raz
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

10.  Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.

Authors:  Roberta Galli; Alessio Paone; Muller Fabbri; Nicola Zanesi; Federica Calore; Luciano Cascione; Mario Acunzo; Antonella Stoppacciaro; Andrea Tubaro; Francesca Lovat; Pierluigi Gasparini; Paolo Fadda; Hansjuerg Alder; Stefano Volinia; Antonio Filippini; Elio Ziparo; Anna Riccioli; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.